Categories
Anupam Rasayan India Limited — Important, 23-05-2026: Agreements
23-05-2026 · 07:43 pm
Anupam Rasayan will acquire up to 74.20% control of Bliss GVS Pharma for ~Rs. 1369.51 Cr (initial stake) plus ~Rs. 829.03 Cr (open offer). This strengthens ARIL's pharma value chain presence, adding niche products and global reach for synergistic growth.
No comments yet. Be the first to comment!